Korea 2021 Roundup: License Deals, Overseas Sales Key Factors In Earnings

Hanmi, GC Pharma, SK Affiliates Strong Performers

A Scrip roundup of 2021 earnings for major Korean pharma firms shows top performers included Hanmi Pharma, GC Pharma and SK Group affiliates, which were boosted by new license deals, strong overseas sales and high-margin vaccines and other products.

earnings
As Korean Pharmas Globalize, License Deal, Overseas Sales Impact Grow • Source: Alamy

More from South Korea

More from Focus On Asia